Agilent Technologies

Sigsense Technologies, Inc. is a private technology company based in San Francisco, California, specializing in equipment monitoring software solutions. Established in 2013, the company has developed a proprietary artificial intelligence platform that provides a comprehensive, vendor-agnostic management solution for equipment operations across various industries. This platform offers real-time performance analysis and actionable insights, enabling predictive maintenance and helping clients identify opportunities for process optimization. By utilizing non-invasive power and environmental IoT sensors, Sigsense's technology gathers detailed data on equipment performance at the component level, which allows for proactive detection of operational issues before failures occur. The primary objective of Sigsense Technologies is to enhance equipment utilization and minimize downtime, thereby maximizing productivity and supporting clients in maintaining a competitive edge in their respective markets.

RareCyte, Inc. is a life sciences company based in Seattle, Washington, specializing in the development of innovative platforms for the analysis of liquid and tissue biopsies. Founded in 2009, the company focuses on the detection and characterization of rare cells, particularly circulating tumor cells (CTCs) and circulating endothelial cells (CECs), which are critical for advancing precision medicine in oncology and cardiovascular disease. RareCyte's AccuCyte system offers an open platform that allows for the unbiased discovery and isolation of these rare cells from whole blood. The company provides a comprehensive suite of products, including sample preparation systems, staining kits, automated microscopy instruments, and imaging systems, which are utilized in various applications such as liquid biopsies, single-cell retrieval, and multi-parameter tissue analysis. By equipping researchers and medical professionals with advanced tools, RareCyte aims to enhance clinical research and foster the development of targeted therapies.

Elegen is a biotechnology company founded in 2017, focused on developing microfluidic technology to advance synthetic biology. Led by Dr. Matthew Hill, Elegen aims to revolutionize the field by engineering entire genomes and creating innovative DNA synthesizers. Their technology is designed to enhance the speed and efficiency of DNA sequence testing, thereby facilitating significant progress in biomedical research and healthcare applications. Through these efforts, Elegen seeks to contribute to the rapid development of solutions that address various challenges in the life sciences sector.

Biofidelity Ltd. is a company focused on the research and development of molecular diagnostic assays designed for the detection of specific DNA sequences. Founded in 2019 and based in Cambridge, United Kingdom, Biofidelity's innovative assays have applications in various fields, including oncology, prenatal testing, infectious disease, and organ transplant monitoring. The company's mission is to enhance patient care by facilitating early disease detection and improving the targeting of treatments, ultimately aiming to improve and extend patients' lives.

HALO X-ray Technologies has been spun out of the Imaging Science Group at Nottingham Trent University and the Cranfield Forensic Institute at Cranfield University. We are developing commercially-focused OEM X-ray diffraction solutions based on novel and patented Focal Construct Technology that provides platform capability across a wide range of application areas. Their initial focus lies in the development of HALO solutions for the aviation security and the medical systems markets. We have strong ties to the aviation sector through a long and prestigious research and development programme that has previously realised novel divergent beam X-ray technology (developed and marketed through various incumbent suppliers such as 3DX-ray Ltd) and kinetic depth systems (developed and marketed through Astrophyscis Inc) as 3rd party solutions. We have a clear focus on medical systems and we are currently part of a consortium recentlly awarded an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. This is an exciting project and we look forward to working with our partners in developing HALO technology for this market.

e-MSion is a biotechnology research service provider focused on enhancing mass spectrometry applications in life sciences. The company specializes in making electron capture dissociation (ECD) fragmentation accessible, which represents a significant advancement in protein mass spectrometry. To achieve this, e-MSion offers a compact add-on device that enables ECD fragmentation in benchtop mass spectrometers for the first time, thereby facilitating more detailed molecular analysis and research capabilities in the field.

Avida Biomed aims to advance molecular diagnostics through genomic tool innovation and integration.

PSS polymer standards service under develops and manufactures. They offer techniques and instrumentation for the characterization, production, optimization of synthetic, natural, and bio-polymers. Company is a perfect separation solutions for polymers, biopolymers, polysaccharides, and proteins.

Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.

Arima Genomics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative solutions for genome sequencing and structural analysis to advance human health and disease research. The company offers Arima-HiC, a proximity ligation kit that captures the three-dimensional organizational structure of chromatin, allowing researchers to understand long-range genomic interactions. Additionally, Arima Genomics provides the Arima-HiChIP protocol, which combines Hi-C and chromatin immunoprecipitation techniques to identify long-range genomic contacts mediated by specific proteins. These technologies are designed to facilitate various genomic applications, such as identifying promoter-enhancer interactions for gene regulation studies and scaffolding contigs for genome assemblies. Arima Genomics was incorporated in 2015 and aims to support genomics discovery through comprehensive services, including study design consultation, sample and library preparation, bioinformatics analysis, and data interpretation.

Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.

PreciseDx is a company specializing in cancer risk stratification by providing patient-specific risk assessments through the analysis of morphological features. Utilizing artificial intelligence and its proprietary Morphology Feature Array™, PreciseDx develops disease-specific assays that offer detailed insights into each patient's risk profile and potential outcomes, thereby enhancing treatment decision-making. The company combines its clinical, regulatory, and translational research expertise to advance technologies in areas such as clinical modeling, patient phenotyping, and image analysis, ultimately aiming to improve patient outcomes and quality of life in the realm of cancer and other diseases.

Nicoya Lifesciences Inc. is a Canadian company based in Kitchener that specializes in developing advanced sensor products for the biotechnology and pharmaceutical industries. Founded in 2012, Nicoya creates instruments designed to analyze biomolecular interactions, including proteins, antibodies, DNA, RNA, and small molecules. Their product lineup includes surface plasmon resonance (SPR) instruments, spectrophotometers, sensor chips, reagents, and accessories, as well as the OpenSPR, a personal label-free biomolecular analysis instrument. In addition to hardware, Nicoya offers software solutions for real-time kinetic analysis, instrument control, and optical peak tracking, enhancing the capabilities of their analytical tools.

Akadeum Life Sciences, Inc. is a life sciences company based in Ann Arbor, Michigan, founded in 2014. The company specializes in manufacturing microbubble cell separation products designed to facilitate the removal of target cells from biological samples. Its product line includes T cell and B cell isolation kits for both human and mouse cells, as well as products for red blood cell depletion. Akadeum utilizes buoyancy-activated cell sorting technology, employing microscopic microbubbles that capture target cells and float them to the surface for efficient removal. This innovative approach enhances the efficiency of downstream testing and analysis for medical practitioners. The company's products are available for purchase online, and it maintains a strategic partnership with Agilent Technologies.

RareCyte, Inc. is a life sciences company based in Seattle, Washington, specializing in the development of innovative platforms for the analysis of liquid and tissue biopsies. Founded in 2009, the company focuses on the detection and characterization of rare cells, particularly circulating tumor cells (CTCs) and circulating endothelial cells (CECs), which are critical for advancing precision medicine in oncology and cardiovascular disease. RareCyte's AccuCyte system offers an open platform that allows for the unbiased discovery and isolation of these rare cells from whole blood. The company provides a comprehensive suite of products, including sample preparation systems, staining kits, automated microscopy instruments, and imaging systems, which are utilized in various applications such as liquid biopsies, single-cell retrieval, and multi-parameter tissue analysis. By equipping researchers and medical professionals with advanced tools, RareCyte aims to enhance clinical research and foster the development of targeted therapies.

MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.

Resolution Bioscience specializes in next-generation cancer diagnostics through its innovative liquid biopsy platform, which analyzes cell-free DNA to provide critical information for personalized treatment plans. By offering over 50 focused panels, the company enables physicians to tailor therapies based on individual patient profiles without the need for invasive biopsy procedures. Additionally, Resolution Bioscience is developing companion diagnostics to facilitate therapeutic approvals, further enhancing treatment precision. The company's commitment to improving cancer outcomes is reflected in its suite of clinical tests designed to guide therapy selection and monitor treatment efficacy over time.

Cardea Bio, Inc. is a biotechnology company based in San Diego, California, focused on developing and commercializing bioelectronics for research and diagnostics. Established in 2013, Cardea utilizes proprietary graphene-based digital biosensors to create advanced biosensor hardware, software, and molecular infrastructure, enabling precision healthcare through improved diagnostic capabilities. The company's product offerings include the AGILE R100, an innovative assay for drug discovery, and the AGILE R200, an automated high-throughput screening solution. Cardea's biosensors convert biomolecular interactions into digital data, allowing for real-time biological signal analysis and access to streaming multi-omics data. Their solutions cater to various applications in life sciences and healthcare, such as small molecule validation, antibody characterization, and biomolecular analysis.

MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

DNA Script is a pioneering company in the field of DNA synthesis, focused on enhancing life science and human health through innovative technology. The company has developed a unique enzymatic process that allows for the production of synthetic DNA using natural enzymes. This technology underpins their benchtop DNA printer, SYNTAX, which enables laboratories to synthesize their own oligonucleotides. By doing so, DNA Script provides researchers with greater control over their workflows, facilitating faster access to essential genomic materials for various applications in molecular biology and genomics. This capability accelerates experimentation and supports the development of new therapeutics, positioning DNA Script as a key player in the biotechnology sector.

Arima Genomics, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative solutions for genome sequencing and structural analysis to advance human health and disease research. The company offers Arima-HiC, a proximity ligation kit that captures the three-dimensional organizational structure of chromatin, allowing researchers to understand long-range genomic interactions. Additionally, Arima Genomics provides the Arima-HiChIP protocol, which combines Hi-C and chromatin immunoprecipitation techniques to identify long-range genomic contacts mediated by specific proteins. These technologies are designed to facilitate various genomic applications, such as identifying promoter-enhancer interactions for gene regulation studies and scaffolding contigs for genome assemblies. Arima Genomics was incorporated in 2015 and aims to support genomics discovery through comprehensive services, including study design consultation, sample and library preparation, bioinformatics analysis, and data interpretation.

MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.

BioTek Instruments, Inc. specializes in the development, manufacturing, and sale of life science instrumentation and software. The company offers a diverse range of products, including multi-mode microplate readers, imaging and microscopy systems, and liquid handling instruments such as microplate washers, dispensers, and pipetting systems. BioTek also provides automation solutions, including robotic microplate stackers, as well as data analysis software and accessories for laboratory applications. Its instruments support various fields, including healthcare, pharmaceuticals, agriculture, and research, facilitating cost-effective analysis and quantification of biomolecules and cellular functions. Headquartered in Winooski, Vermont, BioTek has a global presence with offices and support services in multiple countries, including Germany, China, and the United Kingdom. Founded in 1968, the company operates as a subsidiary of Agilent Technologies, Inc. since 2019.

Purigen Biosystems, Inc. specializes in the manufacture of an ionic purification system aimed at the extraction and purification of nucleic acids from biological samples. Utilizing isotachophoresis, a technique that employs electric fields for the separation and purification of nucleic acids, the company offers an innovative solution that is agnostic to nucleic acid size or sequence. This technology is particularly effective for challenging sample types, including formalin-fixed, paraffin-embedded (FFPE) tissues and low cell counts. Purigen's automated platform processes various biological samples such as mammalian cells, tissue biopsies, plasma, blood, and buccal swabs, delivering ready-to-use DNA or RNA for applications like qPCR, microarray, and next-generation sequencing (NGS) preparations. Founded in 2012 and based in Pleasanton, California, Purigen operates as a subsidiary of Agilent Technologies, providing researchers with a fast and efficient alternative for nucleic acid purification.

Mission Bio, Inc. is a biotechnology company that specializes in tools for studying cellular heterogeneity in human health and life sciences. The company has developed the Tapestri Platform, the first single-cell multi-omics platform, which allows for the simultaneous analysis of genotype and phenotype from the same cell. This platform utilizes proprietary microfluidic droplet technology to enable precise detection of genomic variability at single-cell resolution, facilitating research in various applications, including oncology, blood cancers, solid tumors, and genome editing. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating customized single-cell DNA panels, further enhancing its capabilities in targeted molecular analysis. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

ACEA Biosciences, founded in 2002 and based in San Diego, California, is a biotechnology company specializing in the development and commercialization of advanced microelectronic systems for cell-based assays. The company pioneered real-time, label-free cell analysis technology, marketed globally under the xCELLigence brand, which has garnered over 800 customers and more than 350 peer-reviewed publications. ACEA's innovative iCELLigence instrument, featuring wireless connectivity, enhances accessibility to this technology. In addition to its Life Technology Business Unit, ACEA operates a Therapeutics Business Unit focused on oncology drug discovery and development, utilizing its biosensor technology and a proprietary library of over one million small molecules. The company currently has a program in phase II clinical trials in China, along with several early clinical and preclinical leads. With a strong commitment to scientific collaboration, ACEA Biosciences aims to drive innovation in research and healthcare globally.

ProZyme, Inc., founded in 1990 and based in Hayward, California, specializes in developing and manufacturing specialty proteins and enzymes for diagnostics and research applications. The company provides a range of biochemical reagents and kits for carbohydrate analysis, including tools for glycobiology and purification, as well as various conjugated fluorescent reagents. ProZyme has introduced the GlykoPrep Sample Preparation Platform, designed to streamline glycoprotein sample preparation for drug development, enhancing efficiency and quality. Its offerings support pharmaceutical bioprocessing and drug discovery, catering to both large and small biotechnology and academic institutions worldwide. As of 2018, ProZyme operates as a subsidiary of Agilent Technologies, Inc.

Ultra Scientific is a leading global producer of certified reference materials and laboratory solutions, headquartered in North Kingstown, Rhode Island. The company specializes in manufacturing and supplying a comprehensive catalog of chemical standards, including organic and inorganic standards, calibration standards, and quality control check standards. Its products serve various sectors, including environmental, pharmaceutical, biotechnology, life sciences, molecular testing, food, forensics, chemicals, energy, academia, and government. Ultra Scientific is recognized for its rapid turnaround capabilities, enabling laboratories to efficiently meet their specific needs and maintain compliance with industry standards.

Genohm SA, founded in 2002 and headquartered in Lausanne, Switzerland, specializes in developing cloud-based software solutions for laboratory management. As a subsidiary of Agilent Technologies, the company offers its expertise through its SLims platform, which integrates laboratory information management systems (LIMS) and electronic laboratory notebooks (ELN) with order management features. This platform is designed to streamline and digitize lab workflows, catering to the specific needs of various clients, including biobanks, research and development laboratories, hospitals, and biotech companies. Genohm's solutions enable scientists to effectively manage and organize extensive laboratory data, enhancing operational efficiency and supporting diverse research activities.

LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.

Advanced Analytical Technologies, Inc. specializes in the development, manufacturing, and marketing of high-throughput, fully-automated nucleic acid analysis systems. Based in Ames, Iowa, with a laboratory and sales office in Heidelberg, Germany, the company serves customers in the United States and Germany. Its product offerings include the Fragment Analyzer for DNA and RNA quality control, the Zero Agarose Gel DNA Analyzer for automated DNA fragment analysis, Oligo PRO for assessing the purity of oligonucleotides, and pKa PRO for measuring acid dissociation constants of various compounds. These products cater to both commercial and research needs, enhancing processes in molecular diagnostics, pharmaceuticals, life sciences, agriculture, and biofuels. The company also provides installation, training, warranty, and technical support services through a network of distributors and support centers. Advanced Analytical Technologies, Inc. was incorporated in 1997 and has been a subsidiary of Agilent Technologies, Inc. since 2018.

Luxcel Biosciences Ltd., founded in 2002 and based in Cork, Ireland, specializes in porphyrin-based, phosphorescent oxygen-sensing probes and sensors. The company primarily serves the pharmaceutical, food safety, and packaging industries, providing a range of products including oxygen and pH sensors, as well as assays for mitochondrial function, metabolism, and toxicity. Notable offerings include the MitoXpress–Xtra assay for measuring oxygen consumption, the pH-Xtra assay for monitoring extracellular acidification, and the MitoXpress-Intra assay for assessing cell oxygenation. Luxcel also offers the OpTech system for non-invasive package integrity and shelf-life studies, alongside rapid microbial tests for bacterial detection. The company's tools are utilized in diverse applications such as cell analysis, hepatotoxicity, and food safety testing. Luxcel Biosciences sells its products directly and through authorized distributors, catering to pharmaceutical companies, processed food manufacturers, biotechnology firms, university labs, and research institutes.

NanoCellect Biomedical, Inc. is a company based in San Diego, California, specializing in the development of innovative flow cytometry and cell sorting technologies for life science researchers. Founded in 2009, it offers the WOLF Cell Sorter, which utilizes a closed fluid-path microfluidic cartridge to enable efficient cell sorting while minimizing biohazard risks and shear stress associated with traditional methods. The company’s portfolio includes affordable and compact microfluidic-based instruments and consumables that facilitate cellular analysis essential for drug discovery, single cell-omics, cloning, antibody discovery, and basic research. By simplifying the process of analyzing and sorting distinct cell populations, NanoCellect Biomedical supports biomedical scientists in advancing their research and improving personalized medicine.

Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.

Multiplicom specializes in the development of molecular diagnostics products aimed at medical genetics and clinical laboratory applications. The company manufactures molecular diagnostic kits that facilitate the collection of genetic information, enabling personalized treatment options for patients. These kits are particularly valuable for early identification of congenital defects during pregnancy, thereby supporting effective and affordable healthcare solutions. Through its innovative products, Multiplicom strives to enhance access to personalized medicine in the field of genetics.

Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.

iLab Solutions specializes in web-based management services tailored for academic research institutions, including universities, research hospitals, and independent institutes. The company boasts a diverse clientele, featuring notable NIH-funded organizations. iLab’s offerings encompass a suite of tools designed for laboratory management, which includes functionalities for service request management, sample management, equipment reservation, billing, invoicing, and reporting. The firm employs a scientific advisory team composed of principal investigators from prestigious institutions, ensuring that its services are informed by current research practices. The leadership team at iLab brings extensive experience from various sectors, enhancing the company’s capability to serve its clients. iLab maintains a strong focus on customer support and effective implementation, conducting all software development and user support internally to foster a responsive and stable partnership with its clients. With a track record of significant growth, iLab is positioned as a reliable resource for academic research management, ensuring that institutions can efficiently manage their laboratory operations.

LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.

Seahorse Bioscience specializes in providing analytical instruments, biomanufacturing systems, and consumable labware for biological research and drug discovery. The company is known for its Seahorse extracellular flux (XF) analyzers, which allow for non-invasive profiling of cellular metabolic activity. These instruments enable researchers to assess key metabolic parameters, such as basal oxygen consumption, glycolysis rates, ATP turnover, and respiratory capacity, thereby facilitating the study of mitochondrial dysfunction. Seahorse Bioscience serves a diverse clientele, including scientists at academic institutions, pharmaceutical and biotech companies, and original equipment manufacturers of assay kits and laboratory instruments.

Cartagenia specializes in providing software and services for clinical genetics and molecular pathology laboratories. The company offers a platform designed for the assessment and reporting of clinical genomics data derived from next-generation sequencing and microarrays. This platform facilitates the visualization, assessment, and reporting of genetic data in relation to patient information, enabling genetic labs and clinicians to conduct clinically relevant analyses efficiently. By improving the speed and quality of genetic interpretation and counseling, Cartagenia aims to enhance the overall experience for patients and caregivers.

Gradient Design Automation, Inc. specializes in electro-thermal analysis software that creates three-dimensional temperature maps for chips and system-in-packages (SiP). The company offers several products, including FireBolt, an electro-thermal simulator for digital integrated circuits, and CircuitFire and HeatWave, both simulators designed for analog and mixed-signal integrated circuits. These tools are essential for thermal analysis and validation at various design stages, such as floorplanning, place and route, and package integration. Gradient Design Automation primarily serves integrated circuit designers and semiconductor companies focused on digital and mixed-signal applications in the United States. Founded in 2003, the company is headquartered in Santa Clara, California.

Gen9 is a privately held company based in Cambridge, Massachusetts, focused on advancing synthetic biology to enhance the production of DNA content. Established in 2009 by experts in the field, Gen9 has developed a next-generation gene synthesis technology that enables high-throughput, automated DNA construct production with improved cost efficiency and accuracy compared to traditional methods. The company's innovations aim to support various industries, including enzyme and chemical production, pharmaceuticals, and biofuels, by facilitating the constructive application of synthetic biology techniques to improve genes, pathways, genomes, and organisms.

Aurora SFC Systems, Inc. specializes in the development and manufacturing of supercritical fluid chromatography (SFC) products designed for normal phase separation in laboratory settings. The company offers a range of instruments, including the Agilent 1260 Infinity Analytical SFC system, which features a modular design that integrates the Agilent 1260 Analytical SFC LC and the Aurora SFC Fusion A5 Evolution for efficient pre- and post-conditioning of carbon dioxide. Aurora SFC Systems provides a cost-effective alternative to traditional high-performance liquid chromatography (HPLC), catering to the needs of laboratory chemists both in the United States and internationally.

Dako Denmark A/S provides reagents, instruments, and software for cancer diagnostics to hospital and research laboratories worldwide. It offers pathology products, including reagents and antibodies; pharmacodiagnostic kits and pharmDx; staining instruments and instruments for image analysis; and systems where instruments, reagents, training, and service are integrated, which are used by pathologists for in vitro diagnostics to diagnose cancer and other chronic diseases on the basis of tissue samples. The company also provides flow cytometry products comprising reagents and accessories; instruments for flow cytometry; and systems that are used to analyze cells in blood and other fluids, and are employed in the diagnosis of leukemia, lymphoma, and other diseases. In addition, Dako Denmark A/S offers antibodies, which are used to measure the concentration of protein in blood, urine, and cerebrospinal fluid. It has collaboration with Genentech, OSI Pharmaceuticals, and Roche for the clinical development and application for a Premarket Approval Supplement and CE marking of EGFR pharmDx for use of the EGFR pharmDx test as a potential aid in the assessment of non-small cell lung cancer patients considered for treatment with Tarceva. The company was founded in 1966 and is headquartered in Glostrup, Denmark. Dako was acquired by Agilent Technologies in 2012.

BioSystem Development specializes in creating, manufacturing, and marketing system products aimed at addressing unmet needs in biotechnology and life science research. The company's innovative offerings include cartridges filled with small polymer beads, which facilitate rapid protein analysis for drug developers. By focusing on these specific applications, BioSystem Development supports advancements in research and enhances the efficiency of biotechnological processes.

A description for Halo Genomics is coming soon.

Accelicon Technologies is a privately held company specializing in device-level modeling and validation software for the electronics industry. The firm offers a SPICE model analysis solution aimed at ensuring model quality assurance. Its Model Quality Assurance (MQA) solution serves as a verification platform that facilitates communication between fabrication and design teams by comparing, documenting, and validating models provided by foundries. Additionally, Accelicon provides a modeling platform known as the Model Builder Platform (MBP), which enables modeling engineers to optimize the SPICE model library, aligning it closely with silicon data and specific design requirements. The company is focused on enhancing the accuracy and reliability of electronic circuit design through its innovative software offerings.

Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.

Biocius Life Sciences, Inc. is a company specializing in drug discovery research, established in 2009 and located in Woburn, Massachusetts. As a subsidiary of BioTrove, Inc., Biocius develops advanced technologies, including high-throughput mass spectrometry systems, to facilitate the drug discovery process. The company's innovative approach aims to enhance efficiency and accuracy in identifying potential therapeutic compounds, contributing to advancements in pharmaceutical research and development.

Novelx, established in 2002 and based in Lafayette, California, specializes in manufacturing low-cost, high-resolution electron beam columns. These advanced columns utilize miniaturized modular scanning electron microscope technology to serve a variety of sectors, including commercial, inspection, analysis, lithography, and military applications. The company's focus on affordability and precision positions it as a key player in the electron beam technology market, catering to diverse needs in both industrial and research environments.

Varian, Inc. is a prominent global supplier of scientific instruments and vacuum technologies, primarily catering to life science and industrial applications. The company offers a comprehensive range of products and services, including instruments, vacuum products, laboratory consumable supplies, software, and training, supported by an extensive global distribution network. Varian employs approximately 3,900 individuals and maintains manufacturing facilities across North America, Europe, and Asia Pacific. Through its diverse offerings, Varian plays a critical role in advancing research and development in various scientific fields.

MTS Nano Instruments, Inc. specializes in the development and supply of equipment and software designed to assess the mechanical behavior of nano-scale materials and structures. The company's product offerings include nano-indentation systems, nanomechanical testing systems, and quantitative imaging systems, alongside software such as TestWorks Professional, TestWorks Explorer, and Virtual Indenter. These tools facilitate the setup, execution, and analysis of finite-element simulations and various testing methods. MTS Nano Instruments also provides contract and educational services, catering to academic and industrial researchers in fields such as materials science, semiconductor technology, and life sciences. Founded in 1983 and based in Oak Ridge, Tennessee, the company was previously known as Nano Instruments, Inc. and has operated as a subsidiary of Agilent Technologies since 2008.

RVM Scientific, Inc. manufactures direct heating/cooling systems for gas chromatography capillary columns. The company’s products include low thermal mass retrofits and thermal desorber tubes. It also offers custom gas chromatography modules, which are used for low power consumption applications for portable instruments; high speed separations that use short narrow-bore columns; and column modules with metal columns that are used for high temperature applications.

Escort Instruments Corporation specializes in the manufacture of test and measurement instruments, focusing on general-purpose test tools, process test tools, and automotive diagnostic equipment. The company is dedicated to creating instruments that are portable, facilitating easy installation and maintenance. Escort Instruments distributes its products through a global network of distributors, ensuring that its innovative solutions are accessible to a wide range of industries.

TILL provides extremely flexible, modular systems for all current and future microscopy standards – and complete turnkey solutions for imaging and photometry systems. The majority of TILL’s customers are found in the fields of neurobiology, cell biology, biomedicine and pharmacology. The company’s headquarters are located in the Munich BioRegio (Germany), TILL Photonics’ US operation is based in Rochester, NY

Velocity11 is a life sciences technology company that specializes in designing and manufacturing automation solutions for researchers in the life sciences field. Founded in 1999 by Travis Chow and headquartered in the United States, the company offers a range of instruments, including liquid handling and microplate management products. One of its key offerings is BioCel, a versatile sample processing system that facilitates the assembly of genomics reactions, sample dispensing for compound preparation, and the processing of biological samples in various screening applications. Velocity11 focuses on automation services specifically tailored to drug discovery, genomics, and proteomics, effectively supporting researchers in their scientific endeavors.

Kalabie is a provider of Electronic Lab Notebook (ELN) software, established in 2000. Initially focused on the pharmaceutical and medicinal chemistry markets, Kalabie gained traction in Europe, particularly with clients such as Sanofi-Aventis. The company grew steadily from 2004, enhancing its global presence and solidifying its reputation as a leading solution in the ELN sector. Kalabie's software services support research and development operations by facilitating knowledge and process management, as well as protecting intellectual property within laboratories. The platform ensures high levels of traceability and data security for experimental work, which is crucial for pharmaceutical and dermo-cosmetic companies. In 2007, Kalabie was acquired by Agilent Technologies, further expanding its reach in the lab informatics market.

Stratagene Corporation develops, manufactures, and markets life science research products in the United States and internationally. The company supports advances in science by inventing, manufacturing, and distributing products that simplify, accelerate, and improve research. Its products are used in the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.

PXIT, Inc. develops and manufactures test and measurement systems, primarily for use in high-speed data communications. It also offers signal integrity testing solutions for broadband electro-optical signals. The company’s products include digital communications analyser, bit error rate tester, pattern generator, and synthesizer. It offers its products to telecommunications, data communications, and lighting markets.

Acqiris SA, a privately held company that provides high-speed digitizers and analyzers used in commercial, industrial and government electronics markets.

Xpedion Design Systems, Inc. specializes in providing transistor-level simulation, analysis, and behavioral modeling solutions specifically designed for radio frequency integrated circuit and wireless system-on-chip designers. The company's offerings are tailored to enhance the design process, ensuring accuracy and efficiency for engineers working in these specialized fields.

SynPro Corp. manufactures short synthetic DNA and RNA molecules for the pharmaceutical and biotech industries. Its products are used as components of drugs in clinical trials. It makes synthetic nucleic acids used in biotech research.

Molecular Imaging Corp. specializes in the development and manufacturing of nanotechnology measurement tools. The company produces a range of instruments, including Scanning Probe Microscopy and Atomic Force Microscopy systems, along with their associated accessories, software, and data management solutions. These tools are designed for imaging under controlled temperature and environmental conditions, making them suitable for various research applications. Molecular Imaging Corp. focuses on areas such as life science, biotechnology, electrochemistry, and material and polymer science. By providing advanced nanotechnology measurement solutions, the company enables customers to explore new application areas in both academic and industrial research settings.

Computational Biology Corp. develops microarray-based techniques for understanding gene regulation in disease. The company utilizes ChIP-on-chip technology, which uses chromatin immuno-precipitation (ChIP) to discover how regulatory proteins interact with the genome of living cells.

Silicon Genetics specializes in providing data analysis and management solutions tailored for the life sciences sector, emphasizing molecular biology and statistics. The company's offerings include GeneSpring, a desktop software that visualizes and analyzes genomic expression data; Varia, a genetic analysis tool designed for life science researchers; and GeNet, a scalable repository for storing expression data. Through these products, Silicon Genetics aims to support researchers in managing and interpreting complex biological data effectively.

Sirific Wireless is a semiconductor company specializing in the design and development of CMOS RF transceivers for the wireless communications market. Founded in 2000, the company is headquartered in Richardson, Texas, with additional offices in Waterloo, Canada, and Seoul, Korea. Sirific Wireless offers a range of products, including monolithic multi-mode wireless designs, digital direct conversion products, and Harmony-direct upconversion transmitters. Its NEXUS platform integrates multiple wireless standards such as HSDPA, WCDMA, EDGE, GPRS, and GSM, providing on-chip receive diversity for transceivers suitable for multi-mode and multi-band wireless applications.

TelASIC Communications, Inc. develops remote radio head products for WCDMA/HSDPA and WiMAX/LTE infrastructure applications. The company's products enable the transmission of high output power to deliver high data rates and coverage for mobile TV/video/audio/data-centric 3G data services. TelASIC Communications, Inc. was founded in 2001 and is based in El Segundo, California.

RedSwitch is a supplier of high performance switch fabric silicon solutions for the storage, server, networking, and telecom markets. Incorporated in June 2000 with headquarters in Milpitas, Calif., the company was formed by senior executives and design professionals from HAL Computer Systems Inc. RedSwitch products support leading interconnect standards including InfiniBand(TM), RapidIO (TM), and PCI-Express(TM).

SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.

Big Bear Networks develops optical transponders and subassemblies for network operators.

Qosnetics develops IP-based conformance verification and performance-stressing tools.

Tropian, Inc. develops and provides multimode radio frequency integrated circuits and solutions for wireless devices. The company offers Timestar radio frequency integrated circuit solutions for quad-band cellular handsets; Codestar radio transceivers; and Multistar transceivers. It serves wireless device manufacturers. Tropian, Inc. was formerly known as Premier R.F., Inc.

WaveFront Research, Inc. specializes in the development of advanced optical systems and technologies aimed at addressing challenges that traditional solutions cannot solve. The company offers a range of products, including low-loss optical switches, compact optical time delay systems, and dense alignment-tolerant VCSEL-based optical interconnects for both intra-board and board-to-board applications. Additionally, WaveFront Research produces ultra-lightweight hyperspectral imagers. Its research and development center is equipped with optical, mechanical, and electronics laboratories, along with clean room facilities, machining, prototyping, and assembly areas. The company serves a diverse clientele that includes government, military, and commercial sectors, focusing on innovative optical imaging technologies and products.

Novera Optics specializes in developing optical access solutions aimed at enhancing connectivity in various markets. The company's offerings include PON optical solutions, which cater to equipment vendors and service providers dealing with fiber-to-the-building, fiber-to-the-curb extensions, and multi-dwelling units. Novera Optics also provides Wavelength Division Multiplexed-Passive Optical Networks (WDM-PON), an integrated access and transport platform that facilitates the delivery of voice, data, video, and wireless services. By focusing on fiber-optic technology, Novera Optics addresses bandwidth limitations in copper-based last-mile networks, enabling high-speed carrier Ethernet services to reach customer premises efficiently.

Agilent's Interoperability Certification Labs, Inc. provides third party product testing services. It specializes in test and analysis services, such as performance; benchmarking; interoperability; and functional, certification, and conformance testing. The company offers its services to original equipment manufacturers, systems integrators, and industry groups.

MV Technology Ltd. provides automated optical-inspection systems and solutions for the electronics-manufacturing market.

ATN Microwave is a manufacturer and designer focused on providing microwave measurement solutions tailored for wireless and high-speed data communication applications. The company offers a range of products, including load pull, noise parameter, and s-parameter components, which are essential for enhancing signal integrity in the RF, microwave, and high-speed digital sectors. By ensuring power, accuracy, and stability, ATN Microwave supports its clients in achieving broader coverage and improved performance in their communication systems.

Objective Systems Integrators (OSI) is a global provider of Operations Support Systems (OSS) solutions designed for communications service providers. Since its establishment in 1989, OSI has focused on delivering innovative technology solutions, with its flagship NetExpert® platform offering visibility and service assurance for major service providers worldwide, including those involved in next-generation services like LTE. The NetExpert® platform enables communications service providers, including fixed, broadband, and wireless companies, to efficiently manage their networks, services, products, and customer interactions. It delivers comprehensive service, performance, and fault management for complex networks, allowing operators to monitor service quality at both aggregate and customer levels. OSI's expertise extends to systems integration, software development, and IT consulting services, helping organizations optimize technology investments and achieve their strategic goals through effective integration and support.

Entridia Corporation is an Internet infrastructure company focused on developing advanced silicon-based routing engines that facilitate the convergence of data, voice, and video communications over the Internet. By providing innovative silicon and system solutions, Entridia aims to empower original equipment manufacturers (OEMs) in building the next generation of Internet gateways. Their products are designed to enhance network performance, ensuring reliable and efficient communication for users across various platforms.

SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.

Zymed, Inc. develops and markets inpatient telemetry systems, cardiac analysis software algorithms, and outpatient holter and cardiac event monitoring systems. It serves diagnostic monitoring markets, which include holter, telemetry, event recorder, home cardiac monitoring, intensive/coronary care units, prevention analysis, interventional cardiology, and arrhythmia and ischemia disease management.

American Holographic Inc specializes in the design and manufacture of holographic diffraction gratings and spectral sensor modules. Its products are utilized in a variety of sectors, including fiber optic communications, optical test equipment, pulse compression, and spectrographs. The company serves diverse industrial, research, and scientific applications, providing essential components that enhance the functionality and performance of optical systems.

J&W Scientific, Inc. manufactures scientific instruments such as high resolution gas chromatography columns, flowmeters, syringes, and gas flow and control instruments. The company produces Unimetrics Syringes, Humonics Flowmeters and R&D Separations Gas Filters.